Add-on Acquisition • Medical Products

CooperSurgical Acquires AEGEA Medical

On February 2, 2021, CooperSurgical acquired medical products company AEGEA Medical

Acquisition Context

This is CooperSurgical’s 9th transaction in the Medical Products sector.
This is CooperSurgical’s 9th transaction in the United States.
This is CooperSurgical’s 1st transaction in California.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free

M&A Deal Summary
Date	February 2, 2021
Target	AEGEA Medical
Sector	Medical Products
Buyer(s)	CooperSurgical
Deal Type	Add-on Acquisition

Target Company

AEGEA Medical

Menlo Park, California, United States

AEGEA Medical provides an application for its water vapor ablation technology to deliver therapies that provide high-quality patient outcomes to a wider range of women. AEGEA’s FDA approved Mara Water Vapor Ablation System enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. Founded in 2008, AEGEA Medical is located in Menlo Park, California.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

CooperSurgical

Trumbull, Connecticut, United States

Category	Company
Founded	1990
Sector	Medical Products

DESCRIPTION

CooperSurgical, Inc. is a developer of surgical medical products.

Deal Context for Buyer	#
Overall	13 of 13
Sector: Medical Products	9 of 9
Type: Add-on Acquisition	9 of 9
State: California	1 of 1
Country: United States	9 of 9
Year: 2021	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2017-09-11	Teva Pharmaceutical Industries - PARAGARD Buffalo, New York, United States PARAGARD is a copper-releasing device that is placed in the uterus to prevent pregnancy for up to 10 years.	Buy	$1.1B

DATE

TARGET

DEAL TYPE

VALUE

2017-09-11

Teva Pharmaceutical Industries - PARAGARD

Buffalo, New York, United States

PARAGARD is a copper-releasing device that is placed in the uterus to prevent pregnancy for up to 10 years.

Buy

$1.1B

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2021 M&A